FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Alan Pestronk

Research Profile

Anatomy

Chemicals & Drugs

Disorders

Procedures

Co-author Network

Publications

TOP 3
Timothy M Miller; Daniel A Norris; Lyle W Ostrow; Alan Pestronk; Jeffrey rothstein; David Schoenfeld; Ericka Simpson; Richard Smith; Katie Alexander; Peggy Allred; Patricia L Andres; Stanley H Appel; C Frank Bennett; Kathie M Bishop; Matthew Crisp; William David; Eric A Macklin; Katy Mahoney; Georgios Manousakis; Merit E Cudkowicz
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study.
Craig M Zaidman; Michael J Seelig; Jonathan C Baker; Susan E Mackinnon; Alan Pestronk
Detection of peripheral nerve pathology: Comparison of ultrasound and MRI.
Craig M Zaidman; Mark R Holland; Michael J Noetzel; Tae Sung Park; Alan Pestronk
Newborn brachial plexus palsy: evaluation of severity using quantitative ultrasound of muscle.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Alan Pestronk (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Timothy M Miller; Daniel A Norris; Lyle W Ostrow; Alan Pestronk; Jeffrey rothstein; David Schoenfeld; Ericka Simpson; Richard Smith; Katie Alexander; Peggy Allred; Patricia L Andres; Stanley H Appel; C Frank Bennett; Kathie M Bishop; Matthew Crisp; William David; Eric A Macklin; Katy Mahoney; Georgios Manousakis; Merit E Cudkowicz
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study.
Lancet neurology 2013;12(5):435-42.
2013: Craig M Zaidman; Michael J Seelig; Jonathan C Baker; Susan E Mackinnon; Alan Pestronk
Detection of peripheral nerve pathology: Comparison of ultrasound and MRI.
Neurology 2013;80(18):1634-40.
2013: Craig M Zaidman; Mark R Holland; Michael J Noetzel; Tae Sung Park; Alan Pestronk
Newborn brachial plexus palsy: evaluation of severity using quantitative ultrasound of muscle.
Muscle & nerve 2013;47(2):246-54.
2013: James D Berry; James B Caress; Robin A Conwit; Merit E Cudkowicz; William S David; Donna Felsenstein; Jonathan Glass; David J Greenblatt; Jonathan Katz; Myles Keroack; Lisa Krivickas; Robert Pascuzzi; Alan Pestronk; Kourosh Rezania; Jeffrey Rosenfeld; Jeffrey D Rothstein; David Schoenfeld; Jeremy M Shefner; Ericka Simpson; Francine Vriesendorp
Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis.
PloS one 2013;8(4):e61177.
2012: Ans T Van Der Ploeg; Richard Barohn; Lisa Carlson; Joel Charrow; Paula R Clemens; Robert J Hopkin; Priya S Kishnani; Pascal Laforêt; Claire Morgan; Sharon Nations; Alan Pestronk; Horacio Plotkin; Barry E Rosenbloom; Katherine B Sims; Elisa Tsao
Open-label extension study following the Late-Onset Treatment Study (LOTS) of alglucosidase alfa.
Molecular genetics and metabolism 2012;107(3):456-61.
2012: Alan Pestronk; Robert E Schmidt; R Brian Sommerville; Rati M Choksi; Muhammad T Al-Lozi
Clinical and laboratory features of neuropathies with serum IgM binding to TS-HDS.
Muscle & nerve 2012;45(6):866-72.
2012: Matthew B Harms; Glenn Lopate; Duanduan Ma; Alan Pestronk; R Brian Sommerville; Conrad C Weihl; Peggy Allred; Shaughn Bell; Paul Cooper; Robert H Baloh
Exome sequencing reveals DNAJB6 mutations in dominantly-inherited myopathy.
Annals of neurology 2012;71(3):407-16.
2011: Alan Pestronk
Acquired immune and inflammatory myopathies: pathologic classification.
Current opinion in rheumatology 2011;23(6):595-604.
2011: Craig M Zaidman; Julaine Florence; Elizabeth C Malkus; Alan Pestronk; Catherine Siener; Muhammad T Al-Lozi
Qualitative and quantitative skeletal muscle ultrasound in late-onset acid maltase deficiency.
Muscle & nerve 2011;44(3):418-23.
2011: Diana Escolar; Julaine Florence; L P Hache; Erik K Henricson; F Hu; A J Kornberg; T Lotze; J Mayhew; Craig M McDonald; E Monasterio; Y Nevo; Alan Pestronk; M M Ryan; V Viswanathan; A Zimmerman; A Arrieta; T E Bertorini; P R Clemens; A Cnaan; J W Day; Anne M Connolly
Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy.
Neurology 2011;77(5):444-52.
2011: Christopher F Spurney; Anne M Connolly; Diana Escolar; Julaine Florence; Ksenija Gorni; Erik K Henricson; Fengming Hu; Gerard R Martin; Jill Mayhew; Lei Nie; Livia Pasquali; Alan Pestronk; Carolina Tesi Rocha
CINRG pilot trial of coenzyme Q10 in steroid-treated Duchenne muscular dystrophy.
Muscle & nerve 2011;44(2):174-8.
2011: Glenn Lopate; Alan Pestronk
Inflammatory demyelinating neuropathies.
Current treatment options in neurology 2011;13(2):131-42.
2011: Laura J Merrill; Christina A Gurnett; Anne M Connolly; Alan Pestronk; Matthew B Dobbs
Skeletal muscle abnormalities and genetic factors related to vertical talus.
Clinical orthopaedics and related research 2011;469(4):1167-74.
2011: Kevin M Flanigan; Julaine Florence; Michael T Howard; Katherine D Mathews; Craig M McDonald; Jerry R Mendell; Alan Pestronk; Jacinda B Sampson; Payam Soltanzadeh; Kathryn J Swoboda; Laura E Taylor; Andrew von Niederhausern; Christine B Anderson; Carsten G Bonnemann; Mark B Bromberg; Anne M Connolly; John W Day; Diane M Dunn; Richard S Finkel; Brenda Wong; Robert B Weiss
Nonsense mutation-associated Becker muscular dystrophy: interplay between exon definition and splicing regulatory elements within the DMD gene.
Human mutation 2011;32(3):299-308.
2011: Conrad C Weihl; Sara E Miller; Craig M Zaidman; Alan Pestronk; Robert H Baloh; Muhammad T Al-Lozi
Novel GNE mutations in two phenotypically distinct HIBM2 patients.
Neuromuscular disorders : NMD 2011;21(2):102-5.
2010: Craig M Zaidman; Anne M Connolly; Elizabeth C Malkus; Julaine Florence; Alan Pestronk
Quantitative ultrasound using backscatter analysis in Duchenne and Becker muscular dystrophy.
Neuromuscular disorders : NMD 2010;20(12):805-9.
2010: Arun S Varadhachary; Conrad C Weihl; Alan Pestronk
Mitochondrial pathology in immune and inflammatory myopathies.
Current opinion in rheumatology 2010;22(6):651-7.
2010: Conrad C Weihl; Alan Pestronk
Sporadic inclusion body myositis: possible pathogenesis inferred from biomarkers.
Current opinion in neurology 2010;23(5):482-8.
2010: M B Harms; P Allred; R Gardner; J A Fernandes Filho; Julaine Florence; Alan Pestronk; Muhammad T Al-Lozi; Robert H Baloh
Dominant spinal muscular atrophy with lower extremity predominance: linkage to 14q32.
Neurology 2010;75(6):539-46.
2010: Payam Soltanzadeh; Michael J Friez; Diane Dunn; Andrew von Niederhausern; Olga L Gurvich; Kathryn J Swoboda; Jacinda B Sampson; Alan Pestronk; Anne M Connolly; Julaine M Florence; Richard S Finkel; Carsten G Bönnemann; Livija Medne; Jerry R Mendell; Katherine D Mathews; Brenda L Wong; Michael D Sussman; Jonathan (Jon) Zonana; Karen Kovak; Sidney M Gospe; Eduard Gappmaier; Laura E Taylor; Michael T Howard; Robert B Weiss; Kevin M Flanigan
Clinical and genetic characterization of manifesting carriers of DMD mutations.
Neuromuscular disorders : NMD 2010;20(8):499-504.
2010: Alan Pestronk; Miguel Chuquilin; Rati Choksi
Motor neuropathies and serum IgM binding to NS6S heparin disaccharide or GM1 ganglioside.
Journal of neurology, neurosurgery, and psychiatry 2010;81(7):726-30.
2010: Alan Pestronk; Robert E Schmidt; Rati Choksi
Vascular pathology in dermatomyositis and anatomic relations to myopathology.
Muscle & nerve 2010;42(1):53-61.
2010: Ans T Van Der Ploeg; Paula R Clemens; Deyanira Corzo; Diana M Escolar; Julaine Florence; Geert Jan Groeneveld; Serge Herson; Priya S Kishnani; Pascal Laforet; Stephen L Lake; Dale J Lange; Robert T Leshner; Jill E Mayhew; Claire Morgan; Kenkichi Nozaki; Dorothy J Park; Alan Pestronk; Barry Rosenbloom; Alison Skrinar; Carine I van Capelle; Nadine A van der Beek; Melissa Wasserstein; Sasa A Zivkovic
A randomized study of alglucosidase alfa in late-onset Pompe's disease.
The New England journal of medicine 2010;362(15):1396-406.
2010: Christina A Gurnett; David M Desruisseau; Kevin McCall; Ryan Choi; Zachary I Meyer; Michael Talerico; Sara E Miller; Jeong-Sun Ju; Alan Pestronk; Anne M Connolly; Todd E Druley; Conrad C Weihl; Mathew B Dobbs
Myosin binding protein C1: a novel gene for autosomal dominant distal arthrogryposis type 1.
Human molecular genetics 2010;19(7):1165-73.
2009: Rita Wen Kaspar; Hugh D Allen; Will C Ray; Carlos E Alvarez; John T Kissel; Alan Pestronk; Robert B Weiss; Kevin M Flanigan; Jerry R Mendell; Federica Montanaro
Analysis of dystrophin deletion mutations predicts age of cardiomyopathy onset in becker muscular dystrophy.
Circulation. Cardiovascular genetics 2009;2(6):544-51.
2009: Kevin M Flanigan; Diane M Dunn; Andrew von Niederhausern; Payam Soltanzadeh; Eduard Gappmaier; Michael T Howard; Jacinda B Sampson; Jerry R Mendell; Cheryl Wall; Wendy M King; Alan Pestronk; Julaine M Florence; Anne M Connolly; Katherine D Mathews; Carrie M Stephan; Karla S Laubenthal; Brenda L Wong; Paula J Morehart; Amy Meyer; Richard S Finkel; Carsten G Bonnemann; Livija Medne; John W Day; Joline C Dalton; Marcia K Margolis; Veronica J Hinton; Robert B Weiss
Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort.
Human mutation 2009;30(12):1657-66.
2009: Craig M Zaidman; Muhammad T Al-Lozi; Alan Pestronk
Peripheral nerve size in normals and patients with polyneuropathy: an ultrasound study.
Muscle & nerve 2009;40(6):960-6.
2009: Marta Margeta; Anne M Connolly; Thomas L Winder; Alan Pestronk; Steven A Moore
Cardiac pathology exceeds skeletal muscle pathology in two cases of limb-girdle muscular dystrophy type 2I.
Muscle & nerve 2009;40(5):883-9.
2009: Petra Kaufmann; John L P Thompson; Gilberto Levy; Richard Buchsbaum; Jeremy M Shefner; Lisa S Krivickas; Jonathan Katz; Yvonne Rollins; Richard J Barohn; Carlayne Jackson; Ezgi Tiryaki; Catherine Lomen-Hoerth; Carmel Armon; Rup Tandan; Stacy A Rudnicki; Kourosh Rezania; Robert Sufit; Alan Pestronk; Steven P Novella; Terry D Heiman-Patterson; Edward J Kasarskis; Erik P Pioro; Jacqueline Montes; Rachel Arbing; Darleen Vecchio; Alexandra Barsdorf; Hiroshi Mitsumoto; Bruce Levin
Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III.
Annals of neurology 2009;66(2):235-44.
2009: Kenkichi Nozaki; Alan Pestronk
High aldolase with normal creatine kinase in serum predicts a myopathy with perimysial pathology.
Journal of neurology, neurosurgery, and psychiatry 2009;80(8):904-8.
2009: Conrad C Weihl; Alan Pestronk; Virginia E Kimonis
Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia.
Neuromuscular disorders : NMD 2009;19(5):308-15.
2009: Peyker Temiz; Conrad C Weihl; Alan Pestronk
Inflammatory myopathies with mitochondrial pathology and protein aggregates.
Journal of the neurological sciences 2009;278(1-2):25-9.
2008: J H J Wokke; Diana Escolar; Alan Pestronk; Kenneth M Jaffe; Gregory T Carter; Leonard H Van den Berg; Julaine M Florence; Jill Mayhew; Alison Skrinar; Deyanira Corzo; Pascal Laforet
Clinical features of late-onset Pompe disease: a prospective cohort study.
Muscle & nerve 2008;38(4):1236-45.
2008: Conrad C Weihl; P Temiz; S E Miller; G Watts; C Smith; M Forman; Phyllis I Hanson; V Kimonis; Alan Pestronk
TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia.
Journal of neurology, neurosurgery, and psychiatry 2008;79(10):1186-9.
2008: Paul H Gordon; Ying Kuen Cheung; Bruce Levin; Howard Andrews; Carolyn Doorish; Robert B MacArthur; Jacqueline Montes; Kate Bednarz; Julaine Florence; Julie Rowin; Kevin Boylan; Tahseen Mozaffar; Rup Tandan; Hiroshi Mitsumoto; Elizabeth A Kelvin; John Chapin; Richard S Bedlack; Michael H Rivner; Leo F McCluskey; Alan Pestronk; Michael Graves; Eric J Sorenson; Richard J Barohn; Jerry M Belsh; Jau-Shin Lou; Todd Levine; David Saperstein; Robert G Miller; Stephen N Scelsa
A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS.
Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 2008;9(4):212-22.
2008: Craig M Zaidman; Mark R Holland; Christian C Anderson; Alan Pestronk
Calibrated quantitative ultrasound imaging of skeletal muscle using backscatter analysis.
Muscle & nerve 2008;38(1):893-8.
2008: Kathryn R Wagner; James L Fleckenstein; Anthony A Amato; Richard J Barohn; Katharine Bushby; Diana Escolar; Kevin M Flanigan; Alan Pestronk; Rabi Tawil; Gil I Wolfe; Michelle Eagle; Julaine M Florence; Wendy M King; Shree Pandya; Volker Straub; Paul Juneau; Kathleen Meyers; Cristina Csimma; Tracey Araujo; Robert Allen; Stephanie A Parsons; John M Wozney; Edward R LaVallie; Jerry R Mendell
A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy.
Annals of neurology 2008;63(5):561-71.
2008: Michael A Gitcho; Robert H Baloh; Sumi Chakraverty; Kevin Mayo; Joanne B Norton; Denise Levitch; Kimmo J Hatanpaa; Charles L White; Eileen H Bigio; Richard Caselli; Matt Baker; Muhammad T Al-Lozi; John C Morris; Alan Pestronk; Rosa Rademakers; Alison Goate; Nigel J Cairns
TDP-43 A315T mutation in familial motor neuron disease.
Annals of neurology 2008;63(4):535-8.
2007: Robert H Baloh; Ezequiel Salavaggione; Jeffrey Milbrandt; Alan Pestronk
Familial parkinsonism and ophthalmoplegia from a mutation in the mitochondrial DNA helicase twinkle.
Archives of neurology 2007;64(7):998-1000.
2007: Robert H Baloh; Wojtek Rakowicz; Robert Gardner; Alan Pestronk
Frequent atrophic groups with mixed-type myofibers is distinctive to motor neuron syndromes.
Muscle & nerve 2007;36(1):107-10.
2007: Jacinda B Sampson; S M Smith; A G Smith; J R Singleton; S Chin; Alan Pestronk; Kevin M Flanigan
Paraneoplastic myopathy: response to intravenous immunoglobulin.
Neuromuscular disorders : NMD 2007;17(5):404-8.
2007: Conrad C Weihl; Sara E Miller; Phyllis I Hanson; Alan Pestronk
Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice.
Human molecular genetics 2007;16(8):919-28.
2007: Robert H Baloh; Robert E Schmidt; Alan Pestronk; Jeffrey Milbrandt
Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2007;27(2):422-30.
2006: James E Galvin; Divya Palamand; Jeff Strider; Margherita Milone; Alan Pestronk
The muscle protein dysferlin accumulates in the Alzheimer brain.
Acta neuropathologica 2006;112(6):665-71.
2006: Steven A Moore; Christopher J Shilling; Steven Westra; Cheryl Wall; Matthew P Wicklund; Catherine Stolle; Charlotte A Brown; Daniel Michele; Federica Piccolo; Thomas L Winder; Aaron Stence; Rita Barresi; Nick King; Wendy King; Julaine Florence; Kevin P Campbell; Gerald M Fenichel; Hansell H Stedman; John T Kissel; Robert C Griggs; Shree Pandya; Katherine D Mathews; Alan Pestronk; Carmen Serrano; Daniel Darvish; Jerry R Mendell
Limb-girdle muscular dystrophy in the United States.
Journal of neuropathology and experimental neurology 2006;65(10):995-1003.
2006: Conrad C Weihl; Anne M Connolly; Alan Pestronk
Valproate may improve strength and function in patients with type III/IV spinal muscle atrophy.
Neurology 2006;67(3):500-1.
2006: Mark S Forman; Ian R A Mackenzie; Nigel J Cairns; Eric Swanson; Philip J Boyer; David Drachman; Bharati S Jhaveri; Jason H T Karlawish; Alan Pestronk; Thomas W Smith; Pang-hsien Tu; Giles D J Watts; William R Markesbery; Charles D Smith; Virginia E Kimonis
Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations.
Journal of neuropathology and experimental neurology 2006;65(6):571-81.
2006: Jacinda B Sampson; Steven S Chin; Frederic C Clayton; Alan Pestronk; Kathryn J Swoboda; Kevin M Flanigan
An unusual pathologic feature associated with dermatomyositis.
Neuromuscular disorders : NMD 2006;16(6):391-3.
2006: Alan Pestronk; Ksenija Kos; Glenn Lopate; Muhammad T Al-Lozi
Brachio-cervical inflammatory myopathies: clinical, immune, and myopathologic features.
Arthritis and rheumatism 2006;54(5):1687-96.
2006: Glenn Lopate; Alan Pestronk; Muhammad T Al-Lozi; Timothy Lynch; Julaine Florence; Timothy Miller; Todd Levine; Tom Rampy; Brent Beson; Irena Ramneantu
Peripheral neuropathy in an outpatient cohort of patients with Sjögren's syndrome.
Muscle & nerve 2006;33(5):672-6.
2006: R G Strom; Colin P Derdeyn; Christopher J Moran; DeWitte T Cross; G J Esper; Avi Mazumdar; Muhammad T Al-Lozi; Glenn Lopate; Alan Pestronk
Frequency of spinal arteriovenous malformations in patients with unexplained myelopathy.
Neurology 2006;66(6):928-31.
2006: Todd Levine; Alan Pestronk; Julaine Florence; Muhammad T Al-Lozi; Glenn Lopate; Timothy Miller; Irena Ramneantu; W Waheed; Mikula Stambuk; lee stone; Rati Choksi
Peripheral neuropathies in Waldenström's macroglobulinaemia.
Journal of neurology, neurosurgery, and psychiatry 2006;77(2):224-8.
2006: Conrad C Weihl; Seema Dalal; Alan Pestronk; Phyllis I Hanson
Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation.
Human molecular genetics 2006;15(2):189-99.
2005: Kimberly L Ferrante; Jeremy M Shefner; Hui Zhang; Rebecca A Betensky; M O'Brien; H Yu; M Fantasia; James M Taft; M Flint Beal; Bryan Joseph Traynor; Kristyn Newhall; Peter D Donofrio; J Caress; C Ashburn; B Freiberg; C O'Neill; C Paladenech; T Walker; Alan Pestronk; B Abrams; Julaine Florence; R Renna; J Schierbecker; B Malkus; Merit E Cudkowicz
Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS.
Neurology 2005;65(11):1834-6.
2005: Diana Escolar; Gunnar Buyse; Erik K Henricson; Robert Leshner; Julaine Florence; Jill Mayhew; Carolina Tesi-Rocha; Ksenija Gorni; Livia Pasquali; Kantilal M Patel; Robert J McCarter; Jennifer Huang; Thomas Mayhew; Tulio Bertorini; Jose Carlo; Anne M Connolly; Paula R Clemens; Nathalie Goemans; Susan T Iannaccone; Masanori Igarashi; Yoram Nevo; Alan Pestronk; Sub H Subramony; V Venkataraman Vedanarayanan; Henry Wessel
CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy.
Annals of neurology 2005;58(1):151-5.
2005: Glenn Lopate; Alan Pestronk; S Evans; L Li; David B Clifford
Anti-sulfatide antibodies in HIV-infected individuals with sensory neuropathy.
Neurology 2005;64(9):1632-4.
2005: Glenn Lopate; Alan Pestronk; Muhammad T Al-Lozi
Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone.
Archives of neurology 2005;62(2):249-54.
2004: Jeremy M Shefner; Merit E Cudkowicz; David Schoenfeld; T Conrad; James M Taft; Mark Chilton; Leo Urbinelli; Muhammad Qureshi; Hui Zhang; Alan Pestronk; J Caress; Peter D Donofrio; E Sorenson; Walter G Bradley; C Lomen-Hoerth; Erik P Pioro; K Rezania; M Ross; Robert T Pascuzzi; Terry D Heiman-Patterson; Rup Tandan; Hiroshi Mitsumoto; Jeffrey rothstein; T Smith-Palmer; D MacDonald; D Burke
A clinical trial of creatine in ALS.
Neurology 2004;63(9):1656-61.
2004: Giles D J Watts; Jill Wymer; Margaret J Kovach; Sarju G Mehta; Steven Mumm; Daniel Darvish; Alan Pestronk; Michael P Whyte; Virginia E Kimonis
Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein.
Nature genetics 2004;36(4):377-81.
2004: Alan Pestronk; Julaine Florence; Todd Levine; Muhammad T Al-Lozi; Glenn Lopate; Timothy Miller; Irena Ramneantu; W Waheed; Mikula Stambuk
Sensory exam with a quantitative tuning fork: rapid, sensitive and predictive of SNAP amplitude.
Neurology 2004;62(3):461-4.
2003: Giles D J Watts; M Thorne; Margaret J Kovach; Alan Pestronk; Virginia E Kimonis
Clinical and genetic heterogeneity in chromosome 9p associated hereditary inclusion body myopathy: exclusion of GNE and three other candidate genes.
Neuromuscular disorders : NMD 2003;13(7-8):559-67.
2003: Andrew J Kornberg; Alan Pestronk
Antibody-associated polyneuropathy syndromes: principles and treatment.
Seminars in neurology 2003;23(2):181-90.
2003: Marvin J Stone; Yolonda G McElroy; Alan Pestronk; Janet L Reynolds; Joseph T Newman; Alex W Tong
Human monoclonal macroglobulins with antibody activity.
Seminars in oncology 2003;30(2):318-24.
2003: Morie A Gertz; Athanasios Anagnostopoulos; Kenneth C Anderson; Andrew R Branagan; Morton Coleman; Stanley R Frankel; Sergio Giralt; Todd Levine; Nikhil C Munshi; Alan Pestronk; Vincent Rajkumar; Steve P Treon
Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Seminars in oncology 2003;30(2):121-6.
2003: Alan Pestronk; Julaine Florence; Timothy Miller; Rati Choksi; Muhammad T Al-Lozi; Todd Levine
Treatment of IgM antibody associated polyneuropathies using rituximab.
Journal of neurology, neurosurgery, and psychiatry 2003;74(4):485-9.
2003: Alan Pestronk; Rati Choksi; Eric Logigian; Muhammad T Al-Lozi
Sensory neuropathy with monoclonal IgM binding to a trisulfated heparin disaccharide.
Muscle & nerve 2003;27(2):188-95.
2002: Timothy Miller; Muhammad T Al-Lozi; Glenn Lopate; Alan Pestronk
Myopathy with antibodies to the signal recognition particle: clinical and pathological features.
Journal of neurology, neurosurgery, and psychiatry 2002;73(4):420-8.
2002: Glenn Lopate; Rati Choksi; Alan Pestronk
Severe sensory ataxia and demyelinating polyneuropathy with IgM anti-GM2 and GalNAc-GD1A antibodies.
Muscle & nerve 2002;25(6):828-36.
2002: Anne M Connolly; Richard M Keeling; Elizabeth M Streif; Alan Pestronk; Shobhna Mehta
Complement 3 deficiency and oral prednisolone improve strength and prolong survival of laminin alpha2-deficient mice.
Journal of neuroimmunology 2002;127(1-2):80-7.
2002: Alan Pestronk
Inflammatory and immune myopathies: concepts in diagnosis and treatment.
Journal of child neurology 2002;17(3):205.
2001: Margaret J Kovach; Brook Waggoner; S M Leal; David Gelber; Romesh Khardori; M A Levenstien; C A Shanks; G Gregg; Muhammad T Al-Lozi; T Miller; W Rakowicz; Glenn Lopate; Julaine Florence; G Glosser; Z Simmons; John C Morris; Michael P Whyte; Alan Pestronk; Virginia E Kimonis
Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia.
Molecular genetics and metabolism 2001;74(4):458-75.
2001: Anne M Connolly; Richard M Keeling; Shobhna Mehta; Alan Pestronk; Joshua R Sanes
Three mouse models of muscular dystrophy: the natural history of strength and fatigue in dystrophin-, dystrophin/utrophin-, and laminin alpha2-deficient mice.
Neuromuscular disorders : NMD 2001;11(8):703-12.
2001: Glenn Lopate; Andrew J Kornberg; J Yue; Rati Choksi; Alan Pestronk
Anti-myelin associated glycoprotein antibodies: variability in patterns of IgM binding to peripheral nerve.
Journal of the neurological sciences 2001;188(1-2):67-72.
2001: Gerald M Fenichel; Robert C Griggs; John T Kissel; T I Kramer; Jerry R Mendell; Richard T Moxley; Alan Pestronk; K Sheng; Julaine Florence; Wayne M King; Shree Pandya; V D Robison; H Wang
A randomized efficacy and safety trial of oxandrolone in the treatment of Duchenne dystrophy.
Neurology 2001;56(8):1075-9.
2000: T Mozaffar; Alan Pestronk
Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres.
Journal of neurology, neurosurgery, and psychiatry 2000;68(4):472-8.
1999: Muhammad T Al-Lozi; Alan Pestronk
Organ-specific autoantibodies with muscle weakness.
Current opinion in rheumatology 1999;11(6):483-8.
1999: Yoram Nevo; Muhammad T Al-Lozi; Alexander Parsadanian; Jeffrey L Elliott; Anne M Connolly; Alan Pestronk
Mutation analysis in Emery-Dreifuss muscular dystrophy.
Pediatric neurology 1999;21(1):456-9.
1999: Todd Levine; Alan Pestronk
IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab.
Neurology 1999;52(8):1701-4.
1999: Anne M Connolly; M G Chez; Alan Pestronk; S T Arnold; S Mehta; R K Deuel
Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders.
The Journal of pediatrics 1999;134(5):607-13.
1998: Alan Pestronk
Multifocal motor neuropathy: diagnosis and treatment.
Neurology 1998;51(6 Suppl 5):S22-4.
1998: Todd Levine; Alan Pestronk
Inflammatory myopathy with cytochrome oxidase negative muscle fibers: methotrexate treatment.
Muscle & nerve 1998;21(12):1724-8.
1998: Alan Pestronk; Rati Choksi; WC Yee; Andrew J Kornberg; Glenn Lopate; J Trotter
Serum antibodies to heparan sulfate glycosaminoglycans in Guillain-Barré syndrome and other demyelinating polyneuropathies.
Journal of neuroimmunology 1998;91(1-2):204-9.
1998: Anne M Connolly; Alan Pestronk; Shobhna Mehta; Muhammad T Al-Lozi
Primary alpha-sarcoglycan deficiency responsive to immunosuppression over three years.
Muscle & nerve 1998;21(11):1549-53.
1998: Glenn Lopate; Alan Pestronk; WC Yee
N lines in a myopathy with myosin loss.
Muscle & nerve 1998;21(9):1216-9.
1998: T Mozaffar; Glenn Lopate; Alan Pestronk
Clinical correlates of granulomas in muscle.
Journal of neurology 1998;245(8):519-24.
1998: M I Levin; T Mozaffar; Muhammad T Al-Lozi; Alan Pestronk
Paraneoplastic necrotizing myopathy: clinical and pathological features.
Neurology 1998;50(3):764-7.
1998: Muhammad T Al-Lozi; V B Hemelt; Alan Pestronk
Steroid-responsive myopathy with deficient chondroitin sulfate C in skeletal muscle connective tissue.
Neurology 1998;50(2):526-9.
1997: Muhammad T Al-Lozi; Alan Pestronk; Rati Choksi
A skeletal muscle-specific form of decorin is a target antigen for a serum IgM M-protein in a patient with a proximal myopathy.
Neurology 1997;49(6):1650-4.
1997: Anne M Connolly; Alan Pestronk
Anti-tubulin autoantibodies in acquired demyelinating polyneuropathies.
The Journal of infectious diseases 1997;176 Suppl 2():S157-9.
1997: Yoram Nevo; Alan Pestronk
Acute immune polyneuropathies: correlations of serum antibodies to Campylobacter jejuni and Helicobacter pylori with anti-GM1 antibodies and clinical patterns of disease.
The Journal of infectious diseases 1997;176 Suppl 2():S154-6.
1997: Alan Pestronk; Rati Choksi
Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates.
Neurology 1997;49(5):1289-92.
1997: Glenn Lopate; Alan Pestronk; Andrew J Kornberg; J Yue; Rati Choksi
IgM anti-sulfatide autoantibodies: patterns of binding to cerebellum, dorsal root ganglion and peripheral nerve.
Journal of the neurological sciences 1997;151(2):189-93.
1997: Glenn Lopate; B J Parks; J M Goldstein; WC Yee; G M Friesenhahn; Alan Pestronk
Polyneuropathies associated with high titre antisulphatide antibodies: characteristics of patients with and without serum monoclonal proteins.
Journal of neurology, neurosurgery, and psychiatry 1997;62(6):581-5.
1997: Anne M Connolly; Alan Pestronk; S Mehta; M R Pranzatelli; MJ Noetzel
Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: an analysis of antigenic targets in neural tissues.
The Journal of pediatrics 1997;130(6):878-84.
1997: Gerald M Fenichel; Alan Pestronk; Julaine Florence; V Robison; V Hemelt
A beneficial effect of oxandrolone in the treatment of Duchenne muscular dystrophy: a pilot study.
Neurology 1997;48(5):1225-6.
1997: Alan Pestronk; Rati Choksi; Gregory M. Blume; Glenn Lopate
Multifocal motor neuropathy: serum IgM binding to a GM1 ganglioside-containing lipid mixture but not to GM1 alone.
Neurology 1997;48(4):1104-6.
1997: Gregory M. Blume; Alan Pestronk; B Frank; D R Johns
Polymyositis with cytochrome oxidase negative muscle fibres. Early quadriceps weakness and poor response to immunosuppressive therapy.
Brain : a journal of neurology 1997;120 ( Pt 1)():39-45.
1997: Anne M Connolly; Alan Pestronk; S Mehta; WC Yee; B J Green; C Fellin; R K Olney; R G Miller; W N Devor
Serum IgM monoclonal autoantibody binding to the 301 to 314 amino acid epitope of beta-tubulin: clinical association with slowly progressive demyelinating polyneuropathy.
Neurology 1997;48(1):243-8.
1996: Andrew J Kornberg; Alan Pestronk; Gregory M. Blume; Glenn Lopate; J Yue; A Hahn
Selective staining of the cerebellar molecular layer by serum IgG in Miller-Fisher and related syndromes.
Neurology 1996;47(5):1317-20.
1996: Y Nevo; Alan Pestronk; Andrew J Kornberg; Anne M Connolly; WC Yee; I Iqbal; Lloyd K Shield
Childhood chronic inflammatory demyelinating neuropathies: clinical course and long-term follow-up.
Neurology 1996;47(1):98-102.
1996: Anne M Connolly; Alan Pestronk; G J Planer; J Yue; S Mehta; Rati Choksi
Congenital muscular dystrophy syndromes distinguished by alkaline and acid phosphatase, merosin, and dystrophin staining.
Neurology 1996;46(3):810-14.
1995: Gregory M. Blume; Alan Pestronk; L T Goodnough
Anti-MAG antibody-associated polyneuropathies: improvement following immunotherapy with monthly plasma exchange and IV cyclophosphamide.
Neurology 1995;45(8):1577-80.
1995: Andrew J Kornberg; Alan Pestronk
Chronic motor neuropathies: diagnosis, therapy, and pathogenesis.
Annals of neurology 1995;37 Suppl 1():S43-50.
1995: Muhammad T Al-Lozi; Alan Pestronk; WC Yee; N Flaris
Myopathy and paraproteinemia with serum IgM binding to a high-molecular-weight muscle fiber surface protein.
Annals of neurology 1995;37(1):41-6.
1994: Alan Pestronk; Glenn Lopate; Andrew J Kornberg; Jeffrey L Elliott; Gregory M. Blume; WC Yee; L T Goodnough
Distal lower motor neuron syndrome with high-titer serum IgM anti-GM1 antibodies: improvement following immunotherapy with monthly plasma exchange and intravenous cyclophosphamide.
Neurology 1994;44(11):2027-31.
1994: Alan Pestronk; Rati Choksi; K Bieser; J M Goldstein; Charles H Adler; Richard Caselli; Edwin George
Treatable gait disorder and polyneuropathy associated with high titer serum IgM binding to antigens that copurify with myelin-associated glycoprotein.
Muscle & nerve 1994;17(11):1293-300.
1994: Glenn Lopate; Alan Pestronk
Chronic immune demyelinating neuropathies.
Seminars in neurology 1994;14(2):131-6.
1994: Alan Pestronk; F Li; K Bieser; Rati Choksi; A Whitton; Andrew J Kornberg; J M Goldstein; WC Yee
Anti-MAG antibodies: major effects of antigen purity and antibody cross-reactivity on ELISA results and clinical correlation.
Neurology 1994;44(6):1131-7.
1994: Jeffrey L Elliott; Alan Pestronk
Progression of multifocal motor neuropathy during apparently successful treatment with human immunoglobulin.
Neurology 1994;44(5):967-8.
1994: Muhammad T Al-Lozi; Alan Pestronk; WC Yee; N Flaris; J Cooper
Rapidly evolving myopathy with myosin-deficient muscle fibers.
Annals of neurology 1994;35(3):273-9.
1994: Andrew J Kornberg; Alan Pestronk; K Bieser; Ho W Tony; Guy M McKhann; H S Wu; Z Jiang
The clinical correlates of high-titer IgG anti-GM1 antibodies.
Annals of neurology 1994;35(2):234-7.
1994: Andrew J Kornberg; Alan Pestronk
The clinical and diagnostic role of anti-GM1 antibody testing.
Muscle & nerve 1994;17(1):100-4.
1993: Andrew J Kornberg; Alan Pestronk
Immune-mediated neuropathies.
Current opinion in neurology 1993;6(5):681-7.
1993: Anne M Connolly; Alan Pestronk; J L Trotter; Eva L Feldman; David R Cornblath; R K Olney
High-titer selective serum anti-beta-tubulin antibodies in chronic inflammatory demyelinating polyneuropathy.
Neurology 1993;43(3 Pt 1):557-62.
1991: Alan Pestronk; F Li; John W Griffin; Eva L Feldman; David R Cornblath; J Trotter; S Zhu; WC Yee; D Phillips; D M Peeples
Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin-associated glycoprotein.
Neurology 1991;41(3):357-62.
1991: Alan Pestronk; F Li
Motor neuropathies and motor neuron disorders: association with antiglycolipid antibodies.
Advances in neurology 1991;56():427-32.
1990: Alan Pestronk; Vinay Chaudhry; Eva L Feldman; John W Griffin; David R Cornblath; E H Denys; M Glasberg; Ralph W Kuncl; R K Olney; WC Yee
Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies.
Annals of neurology 1990;27(3):316-26.